SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-215565
Filing Date
2024-09-09
Accepted
2024-09-09 09:10:01
Documents
15
Period of Report
2024-09-09
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d40734d8k.htm   iXBRL 8-K 41583
2 EX-99.1 d40734dex991.htm EX-99.1 22976
6 GRAPHIC g40734dsp05.jpg GRAPHIC 5472
  Complete submission text file 0001193125-24-215565.txt   203650

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ttoo-20240909.xsd EX-101.SCH 2864
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttoo-20240909_lab.xml EX-101.LAB 17234
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttoo-20240909_pre.xml EX-101.PRE 10821
18 EXTRACTED XBRL INSTANCE DOCUMENT d40734d8k_htm.xml XML 3534
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 241286058
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)